Human papillomavirus types 16 and 18 in esophagus squamous cell carcinoma: A meta-analysis

Annals of Epidemiology

Volumn 23, Issue 11, 2013, Pages 726-734

  Yong, Fang ^a   Xudong, Ni ^a   Lijie, Tan ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Human papillomavirus; Meta analysis

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; EMBASE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MEDLINE; META ANALYSIS; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL;

ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN PAPILLOMAVIRUS; META-ANALYSIS;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS;

EID: 84885955104     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.07.002     Document Type: Article

References (86)

1. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010, 19(8):1893-1907.
2. Yahyapour Y., Shamsi-Shahrabadi M., Mahmoudi M., Siadati S., Shahryar S.S., Shokri-Shirvani J., et al. Evaluation of human papilloma virus infection in patients with esophageal squamous cell carcinoma from the Caspian Sea area, north of Iran. Asian Pac J Cancer Prev 2012, 13(4):1261-1266.
3. Islami F., Fedirko V., Tramacere I., Bagnardi V., Jenab M., Scotti L., et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer 2011, 129(10):2473-2484.
4. Stefani E.D., Deneo-Pellegrini H., Ronco A.L., Boffetta P., Correa P., Aune D., et al. Meat consumption, cooking methods, mutagens, and risk of squamous cell carcinoma of the esophagus: a case-control study in Uruguay. Nutr Cancer 2012, 64(2):294-299.
5. Islami F., Pourshams A., Nasrollahzadeh D., Kamangar F., Fahimi S., Shakeri R., et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009, 338:b929.
6. Ciapponi A., Bardach A., Glujovsky D., Gibbons L., Picconi M.A. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One 2011, 6(10):e25493.
7. Kreimer A.R., Clifford G.M., Boyle P., Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14(2):467-475.
8. Stelzer M.K., Pitot H.C., Liem A., Schweizer J., Mahoney C., Lambert P.F. Amousemodel for human anal cancer. Cancer Prev Res (Phila) 2010, 3(12):1534-1541.
9. Castillo A., Koriyama C., Higashi M., Anwar M., Bukhari M.H., Carrascal E., et al. Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol 2011, 17(48):5295-5304.
10. Syrjanen K.J. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 1982, 52(4):283-292.
11. Farhadi M., Tahmasebi Z., Merat S., Kamangar F., Nasrollahzadeh D., Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 2005, 11(8):1200-1203.
12. Dai M., Zhang W.D., Clifford G.M., Gheit T., He B.C., Michael K.M., et al. Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China. Int J Cancer 2007, 121(6):1396-1398.
13. Matsha T., Donninger H., Erasmus R.T., Hendricks D., Stepien A., Parker M.I. Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas. Virology 2007, 369(1):182-190.
14. Mir M.M., Dar J.A., Dar N.A., Syed A.T., Salam I., Lone G.N. The association of beta-catenin gene mutations and human papillomavirus in carcinoma of esophagus in a high-risk population of India. Int J Health Sci (Qassim) 2007, 1(2):177-183.
15. Zhou Y., Pan Y., Zhang S., Shi X., Ning T., Ke Y. Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer. Br J Cancer 2007, 97(2):218-222.
16. Herrera-Goepfert R., Lizano M., Akiba S., Carrillo-Garcia A., Becker-D'Acosta M. Human papilloma virus and esophageal carcinoma in a Latin-American region. World J Gastroenterol 2009, 15(25):3142-3147.
17. Tornesello M.L., Monaco R., Nappi O., Buonaguro L., Buonaguro F.M. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. JClin Virol 2009, 45(1):28-33.
18. Antonsson A., Nancarrow D.J., Brown I.S., Green A.C., Drew P.A., Watson D.I., et al. High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010, 19(8):2080-2087.
19. Liu W.K., Jiang X.Y., Zhang M.P., Zhang Z.X. The relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinoma. Eur J Gastroenterol Hepatol 2010, 22(1):67-74.
20. Wang X., Tian X., Liu F., Zhao Y., Sun M., Chen D., et al. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 2010, 10:19.
21. Goto A., Li C.P., Ota S., Niki T., Ohtsuki Y., Kitajima S., et al. Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. JMed Virol 2011, 83(8):1383-1390.
22. Guo F., Liu Y., Wang X., He Z., Weiss N.S., Madeleine M.M., et al. Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev 2012, 21(5):780-785.
23. Hu J., Li L., Pang L., Chen Y., Yang L., Liu C., et al. HLA-DRB1*1501 and HLA-DQB1*0301 alleles are positively associated with HPV16 infection-related Kazakh esophageal squamous cell carcinoma in Xinjiang China. Cancer Immunol Immunother 2012.
24. Koshiol J., Wei W.Q., Kreimer A.R., Chen W., Gravitt P., Ren J.S., et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010, 127(1):93-100.
25. Cao B., Tian X., Li Y., Jiang P., Ning T., Xing H., et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005, 26(7):1280-1284.
26. Syrjanen K. Geographic origin is a significant determinant of human papillomavirus prevalence in oesophageal squamous cell carcinoma: Systematic review and meta-analysis. Scand J Infect Dis.
27. Sitas F., Egger S., Urban M.I., Taylor P.R., Abnet C.C., Boffetta P., et al. InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. JNatl Cancer Inst 2012, 104(2):147-158.
28. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
29. AOJ S. Kendall's advanced theory of statistics 1994, Edward Arnold, London. 6th ed.
30. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
31. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
32. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
33. Toh Y., Kuwano H., Tanaka S., Baba K., Matsuda H., Sugimachi K., et al. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 1992, 70(9):2234-2238.
34. Chang F., Syrjanen S., Shen Q., Wang L., Wang D., Syrjanen K. Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand J Gastroenterol 1992, 27(7):553-563.
35. Ogura H., Watanabe S., Fukushima K., Masuda Y., Fujiwara T., Yabe Y. Human papillomavirus DNA in squamous cell carcinomas of the respiratory and upper digestive tracts. Jpn J Clin Oncol 1993, 23(4):221-225.
36. Chen B., Yin H., Dhurandhar N. Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers. Hum Pathol 1994, 25(9):920-923.
37. Akutsu N., Shirasawa H., Nakano K., Tanzawa H., Asano T., Kobayashi S., et al. Rare association of human papillomavirus DNA with esophageal cancer in Japan. JInfect Dis 1995, 171(2):425-428.
38. Shibagaki I., Tanaka H., Shimada Y., Wagata T., Ikenaga M., Imamura M., et al. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clin Cancer Res 1995, 1(7):769-773.
39. Suzuk L., Noffsinger A.E., Hui Y.Z., Fenoglio-Preiser C.M. Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer 1996, 78(4):704-710.
40. Mizobuchi S., Sakamoto H., Tachimori Y., Kato H., Watanabe H., Terada M. Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. Jpn J Clin Oncol 1997, 27(1):1-5.
41. Lam K.Y., He D., Ma L., Zhang D., Ngan H.Y., Wan T.S., et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum Pathol 1997, 28(6):657-663.
42. Saegusa M., Hashimura M., Takano Y., Ohbu M., Okayasu I. Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan. Mol Pathol 1997, 50(2):101-104.
43. He D., Zhang D.K., Lam K.Y., Ma L., Ngan H.Y., Liu S.S., et al. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 1997, 72(6):959-964.
44. Lavergne D., de Villiers E.M. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999, 80(5):681-684.
45. Hasegawa M., Ohoka I., Yamazaki K., Hanami K., Sugano I., Nagao T., et al. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 2002, 52(7):442-450.
46. Zhou X.B., Guo M., Quan L.P., Zhang W., Lu Z.M., Wang Q.H., et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003, 9(6):1170-1173.
47. Si H.X., Tsao S.W., Poon C.S., Wang L.D., Wong Y.C., Cheung A.L. Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer 2003, 103(4):496-500.
48. Lu X.M., Zhang Y.M., Lin R.Y., Liang X.H., Zhang Y.L., Wang X., et al. p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China. World J Gastroenterol 2004, 10(19):2775-2778.
49. Liu W.K., Chu Y.L., Zhang F., Chen P., Cheng F., Wang H., et al. The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squamous cell carcinoma. Arch Virol 2005, 150(5):991-1001.
50. Shuyama K., Castillo A., Aguayo F., Sun Q., Khan N., Koriyama C., et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 2007, 96(10):1554-1559.
51. Far A.E., Aghakhani A., Hamkar R., Ramezani A., Pishbigar H.F., Mirmomen S., et al. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand J Infect Dis 2007, 39(1):58-62.
52. Lu X.M., Monnier-Benoit S., Mo L.Z., Xu S.Y., Pretet J.L., Liu Z., et al. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol 2008, 34(7):765-770.
53. Koh J.S., Lee S.S., Baek H.J., Kim Y.I. No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction. Dis Esophagus 2008, 21(2):114-117.
54. Ayshamgul H., Ma H., Ilyar S., Zhang L.W., Abulizi A. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Chin Med J (Engl) 2011, 124(3):341-346.
55. Hussain S., Singh N., Salam I., Bandil K., Yuvaraj M., Akbar Bhat M., et al. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. JRecept Signal Transduct Res 2011, 31(2):147-156.
56. Zhang Q.Y., Zhang D.H., Shen Z.Y., Xu L.Y., Li E.M., Au W.W. Infection and integration of human papillomavirus in esophageal carcinoma. Int J Hyg Environ Health 2011, 214(2):156-161.
57. Abdirad A., Eram N., Behzadi A.H., Koriyama C., Parvaneh N., Akiba S., et al. Human papillomavirus detected in esophageal squamous cell carcinoma in Iran. Eur J Intern Med 2012, 23(2):e59-e62.
58. Poljak M., Cerar A. Human papillomavirus type 16 DNA in oesophageal squamous cell carcinoma. Anticancer Res 1993, 13(6A):2113-2116.
59. Fidalgo P.O., Cravo M.L., Chaves P.P., Leitao C.N., Mira F.C. High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa: assessment by polymerase chain reaction. Cancer 1995, 76(9):1522-1528.
60. Benamouzig R., Jullian E., Chang F., Robaskiewicz M., Flejou J.F., Raoul J.L., et al. Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. Gastroenterology 1995, 109(6):1876-1881.
61. Rugge M., Bovo D., Busatto G., Parenti A.R., Fawzy S., Guido M., et al. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer Epidemiol Biomarkers Prev 1997, 6(3):171-176.
62. Morgan R.J., Perry A.C., Newcomb P.V., Hardwick R.H., Alderson D. Human papillomavirus and oesophageal squamous cell carcinoma in the UK. Eur J Surg Oncol 1997, 23(6):513-517.
63. Kok T.C., Nooter K., Tjong A.H.S.P., Smits H.L., Ter Schegget J.T. No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study Group. Eur J Cancer 1997, 33(11):1865-1868.
64. Poljak M., Cerar A., Seme K. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum Pathol 1998, 29(3):266-271.
65. Talamini G., Capelli P., Zamboni G., Mastromauro M., Pasetto M., Castagnini A., et al. Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer 2000, 86(6):874-878.
66. Astori G., Merluzzi S., Arzese A., Brosolo P., de Pretis G., Maieron R., et al. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Digestion 2001, 64(1):9-14.
67. Awerkiew S., Bollschweiler E., Metzger R., Schneider P.M., Holscher A.H., Pfister H. Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol 2003, 192(3):137-140.
68. Lyronis I.D., Baritaki S., Bizakis I., Tsardi M., Spandidos D.A. Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 2005, 20(1):5-10.
69. Katiyar S., Hedau S., Jain N., Kar P., Khuroo M.S., Mohanta J., et al. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005, 218(1):69-79.
70. Dreilich M., Bergqvist M., Moberg M., Brattstrom D., Gustavsson I., Bergstrom S., et al. High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer 2006, 6:94.
71. Pantelis A., Pantelis D., Ruemmele P., Hartmann A., Hofstaedter F., Buettner R., et al. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. Oncol Rep 2007, 17(5):1243-1248.
72. Matsha T., Erasmus R., Kafuko A.B., Mugwanya D., Stepien A., Parker M.I. Human papillomavirus associated with oesophageal cancer. JClin Pathol 2002, 55(8):587-590.
73. White R.E., Mungatana C., Mutuma G., Robert M.E., Daniel R.W., Topazian M.D., et al. Absence of human papillomavirus in esophageal carcinomas from southwestern Kenya. Dis Esophagus 2005, 18(1):28-30.
74. Bahnassy A.A., Zekri A.R., Abdallah S., El-Shehaby A.M., Sherif G.M. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int 2005, 55(2):53-62.
75. Kiyabu M.T., Shibata D., Arnheim N., Martin W.J., Fitzgibbons P.L. Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol 1989, 13(3):221-224.
76. Togawa K., Jaskiewicz K., Takahashi H., Meltzer S.J., Rustgi A.K. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 1994, 107(1):128-136.
77. Paz I.B., Cook N., Odom-Maryon T., Xie Y., Wilczynski S.P. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997, 79(3):595-604.
78. Turner J.R., Shen L.H., Crum C.P., Dean P.J., Odze R.D. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 1997, 28(2):174-178.
79. Miller B.A., Davidson M., Myerson D., Icenogle J., Lanier A.P., Tan J., et al. Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska Natives. Int J Cancer 1997, 71(2):218-222.
80. Castillo A., Aguayo F., Koriyama C., Torres M., Carrascal E., Corvalan A., et al. Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol 2006, 12(38):6188-6192.
81. Souto Damin A.P., Guedes Frazzon A.P., de Carvalho Damin D., Beck Biehl H., Abruzzi de Oliveira L., Auler R., et al. Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Dis Esophagus 2006, 19(2):64-68.
82. Si H.X., Tsao S.W., Poon C.S., Wong Y.C., Cheung A.L. Physical status of HPV-16in esophageal squamous cell carcinoma. JClin Virol 2005, 32(1):19-23.
83. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63(6):1129-1136.
84. Srinivasan M., Taioli E., Ragin C.C. Human papillomavirus type 16 and 18 in primary lung cancers-a meta-analysis. Carcinogenesis 2009, 30(10):1722-1728.
85. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Humanpapillomavirus type distribution in invasive cervical cancer andhigh-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121(3):621-632.
86. Clifford G.M., Smith J.S., Plummer M., Munoz N., Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88(1):63-73.